Skin cancer Board decisions

The Board granted service connection for skin cancer, finding that the Veteran's condition is due to his in-service exposure to herbicide agents, contaminated water at Camp Lejeune, and ultraviolet rays.

The Board denied service connection for residuals of skin cancer, finding that the evidence did not support a causal relationship between the Veteran's in-service exposure to ionizing radiation and his subsequent development of skin cancer.

The Board remands the claims for service connection for Parkinson's disease, prostate cancer, bilateral choroidal melanoma, malignant melanoma of the back, and a respiratory disability due to outstanding evidence and duty-to-assist errors.

The appeal was granted, restoring service connection for atrial fibrillation (AFIB) effective August 21, 2019. The claim for an earlier effective date for hypertension was denied.

The Board granted service connection for melanoma of the right eye and remanded the claim for basal cell carcinoma of the right cheek and ear due to a need for further evidence.

The Board denied the Veteran's claim for service connection for a skin cancer disability, finding that the evidence does not support a link between his condition and his active duty service.

The Board denied the veteran's claim for service connection for melanoma, finding no evidence of a nexus between his in-service herbicide exposure and his current condition.

The Board remands the claims for further development, including obtaining additional evidence and opinions regarding the Veteran's claimed conditions and toxic exposures during service.

The Board denied service connection for nodular basal cell carcinoma of the left cheek, status post excision as it was not shown in service or related to active duty service.

The Board remands the issues of service connection for skin cancer, ischemic heart disease (IHD), and a lung disability due to insufficient evidence.

The Board remands the claims for service connection for diabetes mellitus type II, hypertension, atrial fibrillation, sleep apnea syndrome, and mycosis fungoides (also claimed as skin cancer) to ensure the VA has met a duty to assist the Veteran.

The Board granted service connection for malignant melanoma and a scar on the right temple, denied an increased rating for PTSD, and granted TDIU.

The Board remands the claim for service connection for skin cancer on the head to obtain an adequate medical opinion regarding its etiology, considering both herbicide exposure and other potential exposures during the Veteran's service.

The Board granted service connection for metastatic malignant melanoma to pulmonary lymph nodes and right upper lobe of the lung, finding that the Veteran's condition was caused by exposures during his active service at Travis AFB.

The Board restored the 30 percent rating for tension headaches and denied a higher rating for hypertension, while remanding service connection for melanoma in-situ.

The Board granted service connection for residuals of skin cancer, to include a scar, based on the Veteran's in-service sun exposure and conceded toxic risk exposure activities. The claim for dermatophytosis was remanded due to an inadequate secondary service connection medical opinion.

The Board remands the Veteran's claim for service connection for skin cancer to obtain additional evidence and an adequate etiology opinion.

The Board denied the Veteran's claim for service connection for skin cancer, finding that there was no evidence of a chronic disease in service or manifestation within one year of separation and that the Veteran's skin cancer was less likely than not related to his active service, including exposures to asbestos, Agent Orange, or radiation.

The Board remands the claim for a new examination to address the severity of the Veteran's service-connected basal cell skin cancer with residual scars of the face, as the previous VA examination was incomplete.

The Board granted service connection for heart condition, hypertension, prostate cancer, and skin cancer due to in-service herbicide exposure but denied service connection for bilateral hearing loss, tinnitus, and obstructive sleep apnea.